Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Peripheral Arterial and Ischemic Cerebrovascular Disease Compared to Veterans With Coronary Heart Disease

American Journal of Cardiology

Volumn 118, Issue 8, 2016, Pages 1144-1149

  Hira, Ravi S ^a   Cowart, Jennifer B ^b,c   Akeroyd, Julia M ^b   Ramsey, David J ^c   Pokharel, Yashashwi ^d   Nambi, Vijay ^b,c,e   Jneid, Hani ^b,c   Deswal, Anita ^b,c   Denktas, Ali ^b,c   Taylor, Addison ^b,c   Nasir, Khurram ^f   Ballantyne, Christie M ^c,e   Petersen, Laura A ^b,c   Virani, Salim S ^b,c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^e HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^f MIAMI CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; ATORVASTATIN; CLOPIDOGREL; DIPYRIDAMOLE; FLUINDOSTATIN; GLUCOSE; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; PITAVASTATIN; PRASUGREL; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN; TICAGRELOR; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; ANTICOAGULANT THERAPY; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; BRAIN ISCHEMIA; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLYCEMIC CONTROL; GUIDELINE DIRECTED MEDICAL THERAPY; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; RISK FACTOR; VETERANS HEALTH; CEREBROVASCULAR DISORDERS; COMPLICATION; CORONARY DISEASE; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PERIPHERAL ARTERIAL DISEASE; PROTOCOL COMPLIANCE; RISK REDUCTION; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; UNITED STATES; VERY ELDERLY; VETERAN;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; BLOOD PRESSURE; BRAIN ISCHEMIA; CEREBROVASCULAR DISORDERS; CORONARY DISEASE; DIABETES MELLITUS; FEMALE; GUIDELINE ADHERENCE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERTENSION; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PERIPHERAL ARTERIAL DISEASE; PLATELET AGGREGATION INHIBITORS; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; RISK REDUCTION BEHAVIOR; UNITED STATES; VETERANS;

EID: 84995768739     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2016.07.027     Document Type: Article

References (30)

1. 1 Bhatt, D.L., Steg, P.G., Ohman, E.M., Hirsch, A.T., Ikeda, Y., Mas, J.L., Goto, S., Liau, C.S., Richard, A.J., Rother, J., Wilson, P.W., REACH Registry Investigators, International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 295 (2006), 180–189.
2. 2 Bensley, R.P., Yoshida, S., Lo, R.C., Fokkema, M., Hamdan, A.D., Wyers, M.C., Chaikof, E.L., Schermerhorn, M.L., Accuracy of administrative data versus clinical data to evaluate carotid endarterectomy and carotid stenting. J Vasc Surg 58 (2013), 412–419.
3. 3 Fan, J., Arruda-Olson, A.M., Leibson, C.L., Smith, C., Liu, G., Bailey, K.R., Kullo, I.J., Billing code algorithms to identify cases of peripheral artery disease from administrative data. J Am Med Inform Assoc 20 (2013), e349–e354.
4. 4 Fokkema, M., Hurks, R., Curran, T., Bensley, R.P., Hamdan, A.D., Wyers, M.C., Moll, F.L., Schermerhorn, M.L., The impact of the present on admission indicator on the accuracy of administrative data for carotid endarterectomy and stenting. J Vasc Surg 59 (2014), 32–38 e31.
5. 5 Metcalfe, A., Neudam, A., Forde, S., Liu, M., Drosler, S., Quan, H., Jette, N., Case definitions for acute myocardial infarction in administrative databases and their impact on in-hospital mortality rates. Health Serv Res 48 (2013), 290–318.
6. 6 Virani, S.S., Woodard, L.D., Akeroyd, J.M., Ramsey, D.J., Ballantyne, C.M., Petersen, L.A., Is high-intensity statin therapy associated with lower statin adherence compared with low- to moderate-intensity statin therapy? Implications of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guidelines. Clin Cardiol 37 (2014), 653–659.
7. 7 Virani, S.S., Woodard, L.D., Landrum, C.R., Pietz, K., Wang, D., Ballantyne, C.M., Petersen, L.A., Institutional, provider, and patient correlates of low-density lipoprotein and non-high-density lipoprotein cholesterol goal attainment according to the Adult Treatment Panel III guidelines. Am Heart J 161 (2011), 1140–1146.
8. 8 Virani, S.S., Woodard, L.D., Ramsey, D.J., Urech, T.H., Akeroyd, J.M., Shah, T., Deswal, A., Bozkurt, B., Ballantyne, C.M., Petersen, L.A., Gender disparities in evidence-based statin therapy in patients with cardiovascular disease. Am J Cardiol 115 (2015), 21–26.
9. 9 Solberg, L.I., Engebretson, K.I., Sperl-Hillen, J.M., Hroscikoski, M.C., O'Connor, P.J., Are claims data accurate enough to identify patients for performance measures or quality improvement? the case of diabetes, heart disease, and depression. Am J Med Qual 21 (2006), 238–245.
10. 10 Beard, A.J., Hofer, T.P., Downs, J.R., Lucatorto, M., Klamerus, M.L., Holleman, R., Kerr, E.A., Diabetes Clinical Action Measures Workgroup, Assessing appropriateness of lipid management among patients with diabetes mellitus: moving from target to treatment. Circ Cardiovasc Qual Outcomes 6 (2013), 66–74.
11. 11 Woodard, L.D., Landrum, C.R., Urech, T.H., Profit, J., Virani, S.S., Petersen, L.A., Treating chronically ill people with diabetes mellitus with limited life expectancy: implications for performance measurement. J Am Geriatr Soc 60 (2012), 193–201.
12. 12 Woodard, L.D., Landrum, C.R., Urech, T.H., Wang, D., Virani, S.S., Petersen, L.A., Impact of clinical complexity on the quality of diabetes care. Am J Manag Care 18 (2012), 508–514.
13. 13 Stone, N.J., Robinson, J.G., Lichtenstein, A.H., Bairey Merz, C.N., Blum, C.B., Eckel, R.H., Goldberg, A.C., Gordon, D., Levy, D., Lloyd-Jones, D.M., McBride, P., Schwartz, J.S., Shero, S.T., Smith, S.C. Jr., Watson, K., Wilson, P.W., American College of Cardiology/American Heart Association Task Force on Practice Guidelines, 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63 (2014), 2889–2934.
14. 14 Fihn, S.D., Gardin, J.M., Abrams, J., Berra, K., Blankenship, J.C., Dallas, A.P., Douglas, P.S., Foody, J.M., Gerber, T.C., Hinderliter, A.L., King, S.B. 3rd, Kligfield, P.D., Krumholz, H.M., Kwong, R.Y., Lim, M.J., Linderbaum, J.A., Mack, M.J., Munger, M.A., Prager, R.L., Sabik, J.F., Shaw, L.J., Sikkema, J.D., Smith, C.R. Jr., Smith, S.C. Jr., Spertus, J.A., Williams, S.V., American College of Cardiology Foundation, American Heart Association Task Force on Practice Guidelines, American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography, Interventions, Society of Thoracic Surgeons, 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 60 (2012), e44–e164.
15. 15 Kernan, W.N., Ovbiagele, B., Black, H.R., Bravata, D.M., Chimowitz, M.I., Ezekowitz, M.D., Fang, M.C., Fisher, M., Furie, K.L., Heck, D.V., Johnston, S.C., Kasner, S.E., Kittner, S.J., Mitchell, P.H., Rich, M.W., Richardson, D., Schwamm, L.H., Wilson, J.A., American Heart Association Stroke Council, Council on Cardiovascular, Stroke Nursing Council on Clinical Cardiology, Council on Peripheral Vascular Disease, Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 45 (2014), 2160–2236.
16. 16 Rooke, T.W., Hirsch, A.T., Misra, S., Sidawy, A.N., Beckman, J.A., Findeiss, L.K., Golzarian, J., Gornik, H.L., Halperin, J.L., Jaff, M.R., Moneta, G.L., Olin, J.W., Stanley, J.C., White, C.J., White, J.V., Zierler, R.E., Society for Cardiovascular Angiography, Interventions, Society of Interventional Radiology, Society for Vascular Medicine, Society for Vascular Surgery, 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol 58 (2011), 2020–2045.
17. 17 Hirsch, A.T., Hartman, L., Town, R.J., Virnig, B.A., National health care costs of peripheral arterial disease in the Medicare population. Vasc Med 13 (2008), 209–215.
18. 18 Society for Vascular Surgery Lower Extremity Guidelines Writing Group, Conte, M.S., Pomposelli, F.B., Clair, D.G., Geraghty, P.J., McKinsey, J.F., Mills, J.L., Moneta, G.L., Murad, M.H., Powell, R.J., Reed, A.B., Schanzer, A., Sidawy, A.N., Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication. J Vasc Surg 61 (2015), 2S–41S.
19. 19 Subherwal, S., Patel, M.R., Tang, F., Smolderen, K.G., Jones, W.S., Tsai, T.T., Ting, H.H., Bhatt, D.L., Spertus, J.A., Chan, P.S., Socioeconomic disparities in the use of cardioprotective medications among patients with peripheral artery disease: an analysis of the American College of Cardiology's NCDR PINNACLE registry. J Am Coll Cardiol 62 (2013), 51–57.
20. 20 Subherwal, S., Patel, M.R., Kober, L., Peterson, E.D., Jones, W.S., Gislason, G.H., Berger, J., Torp-Pedersen, C., Fosbol, E.L., Missed opportunities: despite improvement in use of cardioprotective medications among patients with lower-extremity peripheral artery disease, underuse remains. Circulation 126 (2012), 1345–1354.
21. 21 Hirsch, A.T., Criqui, M.H., Treat-Jacobson, D., Regensteiner, J.G., Creager, M.A., Olin, J.W., Krook, S.H., Hunninghake, D.B., Comerota, A.J., Walsh, M.E., McDermott, M.M., Hiatt, W.R., Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 286 (2001), 1317–1324.
22. 22 Mechtouff, L., Touze, E., Steg, P.G., Ohman, E.M., Goto, S., Hirsch, A.T., Rother, J., Aichner, F.T., Weimar, C., Bhatt, D.L., Alberts, M.J., Mas, J.L., REACH Registry Investigators, Worse blood pressure control in patients with cerebrovascular or peripheral arterial disease compared with coronary artery disease. J Intern Med 267 (2010), 621–633.
23. 23 Lewington, S., Clarke, R., Qizilbash, N., Peto, R., Collins, R., Prospective Studies, C., Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360 (2002), 1903–1913.
24. 24 Turnbull, F., Neal, B., Algert, C., Chalmers, J., Chapman, N., Cutler, J., Woodward, M., MacMahon, S., Blood Pressure Lowering Treatment Trialists Collaboration, Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials. Arch Intern Med 165 (2005), 1410–1419.
25. 25 Rosendorff, C., Lackland, D.T., Allison, M., Aronow, W.S., Black, H.R., Blumenthal, R.S., Cannon, C.P., de Lemos, J.A., Elliott, W.J., Findeiss, L., Gersh, B.J., Gore, J.M., Levy, D., Long, J.B., O'Connor, C.M., O'Gara, P.T., Ogedegbe, O., Oparil, S., White, W.B., American Heart Association American College of Cardiology, American Society of Hypertension, Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension. J Am Coll Cardiol 65 (2015), 1998–2038.
26. 26 Psaty, B.M., Manolio, T.A., Smith, N.L., Heckbert, S.R., Gottdiener, J.S., Burke, G.L., Weissfeld, J., Enright, P., Lumley, T., Powe, N., Furberg, C.D., Cardiovascular Health Study, Time trends in high blood pressure control and the use of antihypertensive medications in older adults: the Cardiovascular Health Study. Arch Intern Med 162 (2002), 2325–2332.
27. 27 Wang, T.J., Vasan, R.S., Epidemiology of uncontrolled hypertension in the United States. Circulation 112 (2005), 1651–1662.
28. 28 Hemmingsen, B., Lund, S.S., Gluud, C., Vaag, A., Almdal, T.P., Hemmingsen, C., Wetterslev, J., Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus. Cochrane Database Syst Rev, 11, 2013, CD008143.
29. 29 McDermott, M.M., Hahn, E.A., Greenland, P., Cella, D., Ockene, J.K., Brogan, D., Pearce, W.H., Hirsch, A.T., Hanley, K., Odom, L., Khan, S., Criqui, M.H., Lipsky, M.S., Hudgens, S., Atherosclerotic risk factor reduction in peripheral arterial diseasea: results of a national physician survey. J Gen Intern Med 17 (2002), 895–904.
30. 30 McDermott, M.M., Mandapat, A.L., Moates, A., Albay, M., Chiou, E., Celic, L., Greenland, P., Knowledge and attitudes regarding cardiovascular disease risk and prevention in patients with coronary or peripheral arterial disease. Arch Intern Med 163 (2003), 2157–2162.